Sandostatin LAR depot 30 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FQV4D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,895
Award facts
- Contract value 100% obligated
- $89,895.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $89,895.33 by the Defense Logistics Agency on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in treating acromegaly and neuroendocrine tumors. The award was issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
Amerisourcebergen Drug Corp's performance location is listed as Conshohocken, Pennsylvania, the company's headquarters location. As a major pharmaceutical distributor and critical federal vendor, Amerisourcebergen demonstrates capability to fulfill specialized medical procurement requirements through open competition. The Defense Logistics Agency's Medical Supply Chain relies on such vendors to deliver essential medications and medical commodities to support military treatment facilities and veteran healthcare programs worldwide. This delivery order exemplifies the routine fulfillment of specialized pharmaceutical needs under the larger DLA prime vendor agreement.
Quick answers
Who was awarded contract SPE2DR26FQV4D?
SPE2DR26FQV4D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV4D worth?
The government has obligated $89,895 on SPE2DR26FQV4D.
Is contract SPE2DR26FQV4D an order under another contract?
Yes. SPE2DR26FQV4D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV4D competed?
The extent of competition for SPE2DR26FQV4D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award